SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Interim Management Statement

19 Jan 2012 07:00

RNS Number : 8030V
Oxford Instruments PLC
19 January 2012
 



Oxford Instruments plc

 

Interim Management Statement

 

19 January 2012

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues an Interim Management Statement which covers the period from 1 October 2011 to date.

Orders within both our Research and Industrial markets remained robust with the exception that, as expected, orders for High Brightness LED related equipment within our Plasma Technology business unit have fallen as overcapacity in this industry takes effect. Despite this, orders, sales and profits for the Group for the year to date and for the third quarter are ahead of the corresponding period last year and consistent with our expectations.

On 20 October 2011 the Group disposed of a non-core Industrial product line that we produced for a single customer, to that customer. A consideration of £7.1 million was paid on completion, with a further £1.0 million receivable on the completion of a Transitional Services Agreement.

On 4 November 2011 the Group announced the acquisition of Platinum Medical Imaging LLC (Platinum) for an initial debt free, cash free consideration of US$18 million with a deferred element of up to US$37 million payable over three years dependent on its performance over that period. The combination of Platinum with our existing MRI Service business in North America significantly strengthens the Group's Service Sector offering, and its integration is progressing to plan.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

Our broad spread of geographies and technologies, and our strong pipeline of new products should help us to remain resilient in the event of a global economic downturn. The Board anticipates that Oxford Instruments will continue to make good progress in line with its expectations for the remainder of the financial year and consistent with its 14 cubed objectives.

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Ian Payne

 

 

This Interim Management Statement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the Statement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

 

 

Notes to Editors

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and is a member of the FTSE250 index on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its' products, expertise, and ideas address global issues such as energy, environment and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRGDBGDBBGDI
Date   Source Headline
6th Jun 20172:14 pmPRNTotal Voting Rights
4th May 20171:56 pmPRNTotal Voting Rights
26th Apr 20177:30 amRNSSale of Industrial Analysis business to HHT
13th Apr 20177:00 amRNSTrading Statement
3rd Apr 20173:25 pmPRNTotal Voting Rights
27th Feb 20179:34 amPRNHolding(s) in Company
2nd Feb 20171:25 pmPRNTotal Voting Rights
31st Jan 20174:31 pmPRNHolding(s) in Company
30th Jan 20174:43 pmPRNHolding(s) in Company
3rd Jan 201711:30 amPRNBlocklisting - Interim Review
18th Nov 20167:00 amRNSDisposal
15th Nov 20167:00 amRNSHalf-year Report
14th Nov 201612:52 pmPRNDirector Declaration
1st Nov 201611:07 amPRNTotal Voting Rights
26th Oct 20167:00 amPRNHolding(s) in Company
14th Sep 201610:17 amPRNResult of AGM
13th Sep 20167:00 amRNSAGM Statement
1st Aug 20164:14 pmPRNTotal Voting Rights
5th Jul 20161:26 pmPRNTotal Voting Rights
5th Jul 20161:19 pmPRNBlocklisting - Interim Review
21st Jun 20162:51 pmPRNDirector/PDMR Shareholding
15th Jun 20167:00 amRNSFinal Results
13th Jun 20161:44 pmPRNDirector/PDMR Shareholding
7th Jun 20163:31 pmRNSDirectorate Change
12th May 20164:26 pmPRNDirector/PDMR Shareholding
9th May 20167:00 amRNSDirectorate Change
18th Apr 20167:00 amPRNDirector/PDMR Shareholding
11th Apr 201610:49 amPRNDirectorate Change
14th Mar 20163:54 pmPRNDirector/PDMR Shareholding
3rd Mar 201611:03 amPRNHolding(s) in Company
24th Feb 20163:47 pmPRNHolding(s) in Company
24th Feb 20167:00 amRNSDirector Declaration & Directorate Change
23rd Feb 201611:52 amPRNNotification of Home State
16th Feb 201611:07 amPRNDirector/PDMR Shareholding
12th Feb 20167:00 amRNSAppointment of Group Finance Director
2nd Feb 20167:00 amRNSAppointment of Non-Executive Director
22nd Jan 20167:00 amRNSTrading Statement
15th Jan 20167:00 amRNSNotice of Trading Update
14th Jan 20161:51 pmPRNDirector/PDMR Shareholding
4th Jan 201612:07 pmPRNBlocklisting - Interim Review
1st Dec 201510:37 amPRNHolding(s) in Company
26th Nov 20153:41 pmPRNHolding(s) in Company
24th Nov 20157:00 amRNSDisposal
12th Nov 20152:23 pmPRNDirector/PDMR Shareholding
10th Nov 20153:23 pmPRNHolding(s) in Company
10th Nov 20157:01 amRNSDirectorate Changes
10th Nov 20157:00 amRNSHalf Yearly Report
27th Oct 201510:06 amRNSReplacement re: Directorate Change
27th Oct 20157:00 amRNSDirectorate Change
14th Oct 201511:09 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.